The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion

Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer

(2011) Tugan Bese et al.   Journal of Gynecologic Oncology

Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism

(2010) Soon Young Park et al.   INTERNATIONAL JOURNAL OF CANCER

Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

(2010) S Y Park et al.   ONCOGENE

Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer

(2010) Iva Sedláková et al.   TUMOR BIOLOGY

Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: Their inhibition by curcumin

(2009) Ji Hye Seo et al.   CANCER LETTERS

The suppressive effect of Rho kinase inhibitor, Y-27632, on oncogenic Ras/RhoA induced invasion/migration of human bladder cancer TSGH cells

(2009) Horng-Rong Chang et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer

(2008) Akiko Horiuchi et al.   CANCER SCIENCE

Rho GTPases in cancer cell biology

(2008) Francisco M. Vega et al.   FEBS LETTERS